HR+ HER2- Breast Cancer and Triple Negative Breast Cancer, with inclusion of HER2 Low Breast Cancer

Details

Files
Project Status:
Complete
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0033-000

Review Type: Panel

Provisional Funding Algorithm

Stakeholder Input Deadline:  August 11, 2023
Draft Report Posted: October 26, 2023
Stakeholder Feedback Deadline: November 2, 2023
Final Report Posted: December 7, 2023